Clinical Trial Update: Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating lenvatinib and eribulin in advanced soft tissue sarcoma has completed with posted results. The study includes leiomyosarcoma and lipo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Halaven (eribulin)
• LENVIMA (lenvatinib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Leiomyosarcoma, Liposarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-25